Michael Charlton
Madrigal Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, Hepatitis B Virus Studies, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases(2017)7,169 cited
- → The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association(2012)3,804 cited
- → The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology(2012)1,766 cited
- → A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis(2024)1,493 cited
- → Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States(2011)1,104 cited
- → Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis(2015)799 cited